INVITRO ACTIVITY OF 5 QUINOLINE DERIVATIVES AGAINST NOSOCOMIAL ISOLATES OF STAPHYLOCOCCUS AND PSEUDOMONAS SPECIES

被引:6
作者
DASCHNER, FD
JUST, HM
机构
关键词
D O I
10.1007/BF02148670
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:72 / 73
页数:2
相关论文
共 4 条
[1]   INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].
BAUERNFEIND, A ;
PETERMULLER, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115
[3]   A LABORATORY ASSESSMENT OF CIPROFLOXACIN AND COMPARABLE ANTIMICROBIAL AGENTS [J].
SHRIRE, L ;
SAUNDERS, J ;
TRAYNOR, R ;
KOORNHOF, HJ .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (04) :328-332
[4]   INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].
WISE, R ;
ANDREWS, JM ;
EDWARDS, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564